Market Capitalization of Concord Biotech (CONCORDBIO)
As of April 30, 2026, Concord Biotech (CONCORDBIO) market capitalisation is ₹11874.99 Cr ($1.32B), with 10.40 Cr shares outstanding at a current price of ₹1142.00 on NSE, ranking 508 out of 5362 companies by market cap in our screener. Concord Biotech operates in the Healthcare sector and is classified as a Mid Cap stock. Read CONCORDBIO dividend track record for the complete payout history and dividend yield track record.
Market Cap History of Concord Biotech (Last 10 Years)
CONCORDBIO market capitalisation from year-end NSE closing prices over the last 10 years. Analyse CONCORDBIO institutional holdings to track promoter, FII and institutional holdings.
End of Year Market Cap History — Concord Biotech
CONCORDBIO year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see Concord Biotech share price screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹11874.99 Cr
$1.32B USD
|
₹1142.00 | NSE | -15.13% |
| 2025 |
₹13992.11 Cr
$1.55B USD
|
₹1345.60 | NSE | -39.13% |
| 2024 |
₹22988.30 Cr
$2.55B USD
|
₹2210.75 | NSE | +50.21% |
| 2023 |
₹15304.39 Cr
$1.70B USD
|
₹1471.80 | NSE | - |